PPT-Management of Type II Diabetes in Patients with Kidney Transplantation

Author : adia | Published Date : 2022-02-12

Brendan Peterson Objectives Review background information Determine special considerations for pharmacotherapy in T2DM kidney transplant patients Summarize evidencebased

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Management of Type II Diabetes in Patien..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Management of Type II Diabetes in Patients with Kidney Transplantation: Transcript


Brendan Peterson Objectives Review background information Determine special considerations for pharmacotherapy in T2DM kidney transplant patients Summarize evidencebased treatment recommendations. How to involve people with diabetes and CKD in their own . care . –. what information must they have to manage their own condition effectively?. Objectives and background for this learning resource. Assocation. Clinical Practice Guidelines. Pancreas and Islet Cell Transplant. Chapter 20. Breay. . W. . Paty. , . Angela . Koh. , Peter Senior. 2013. Key Points. Simultaneous . pancreas-kidney . transplant in T1DM . 1. AACE Comprehensive Diabetes Care: Glucose Goals . Parameter. Treatment Goal for . Nonpregnant. Adults. A1C (%). . Individualize based on age, comorbidities, and duration of disease*. ≤6.5 for most. Gary . Strokosch. , MD. Region V Medical Specialist. Type 2. Drew Alexander, MD. Region IV Medical Specialist. November 4, 2013. Two Main Types of Diabetes. Type 1: formerly known as insulin-dependent diabetes mellitus (IDDM) or juvenile onset diabetes. 1. History . Since early times the idea of tissue and organ transplantation has captured the imagination of successive generations. Early attempts at organ transplantation were ended with failure due to . . nodushan. Fellow of endocrinology. Research institute for endocrine sciences. . . Shahid. . Beheshti. University of Medical Sciences.. Jul.2017. Agenda. Prevalence. Natural history . In both of the common types of diabetes, environmental factors interact with genetic susceptibility to determine which people develop the clinical syndrome, and the timing of its onset.. However, the underlying genes, precipitating environmental factors and pathophysiology differ substantially between type 1 and type 2 diabetes.. Definition. Type 1 Diabetes. : This refers to a genetically based condition in which the cells in the pancreas that normally produce a hormone called “Insulin” stop functioning. This often appears in childhood or early adolescence. The only treatment for Type 1 Diabetes is insulin replacement (by pump or injection). Without adequate supplementary insulin, blood sugar levels dramatically increase and glucose “spills over” into the urine.. 116 SIGN guidelines are produced using a standard methodology that has been equality impact assessed to ensure that these equality Scottish Intercollegiate Guidelines NetworkManagement of diabetesA Dr. Sandra Neoh. , Endocrinologist. with thanks to . Dr. . Mervyn. . Kyi. , Endocrinologist. TNH Intern Teaching 2019. Point Prevalence Study. 351 patients (82% of all beds) across TNH, BHS, BECC surveyed. Fereidoun. . Azizi. , M.D.. Professor of Internal Medicine & Endocrinology. Research institute for Endocrine Sciences. Shahid. . Beheshti. University of Medical Sciences. Tehran, I.R. Iran. Ramadan & Health Conference. transplantation - the . role of. desensitization . protocols. Milica . Kravljaca. Clinic of Nephrology University Clinical Center of Serbia. Faculty of Medicine University of Belgrade. What are the key challenges in kidney transplantation today?. Download PDF The Diabetes Loophole™ eBook by Reed Wilson - A detailed program aimed at helping you understand and address your body\'s requirements when experiencing diabetes symptoms. Dr Jean . Filipov. , PhD. UH . Alexandrovska. Sofia, Bulgaria. Plan of the presentation. Biochemical abnormalities after kidney transplantation (KT). Bone disease after KT. Vascular involvement after KT.

Download Document

Here is the link to download the presentation.
"Management of Type II Diabetes in Patients with Kidney Transplantation"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents